ENRIQUE
ALAVA CASADO
Forscher in der Zeit 2012-2013
Instituto de Biomedicina de Sevilla
Sevilla, EspañaPublikationen in Zusammenarbeit mit Forschern von Instituto de Biomedicina de Sevilla (1)
2015
-
Trabectedin efficacy in Ewing sarcoma is greatly increased by combination with anti-IGF signaling agents
Clinical Cancer Research, Vol. 21, Núm. 6, pp. 1373-1382